17 November 2016
: Case report
Rapidly Sequential and Fatal Hemorrhaging in a Case of Cerebral Amyloid Angiopathy
Unusual clinical course, Challenging differential diagnosis, Educational Purpose (only if useful for a systematic review or synthesis)
Zachary B. BulwaABCDEF, G. Carter WardABCDEF, Owen KramerABCDEF, Birju RaoABCDEF, Melvin WichterABCDEFDOI: 10.12659/AJCR.900498
Am J Case Rep 2016; 17:860-863
Abstract
BACKGROUND: Cerebral amyloid angiopathy (CAA) is an increasingly recognized cause of lobar intracerebral hemorrhage (ICH) and cognitive impairment in the aging population. Magnetic resonance imaging (MRI) of cerebral microbleeds is the most reliable option for clinical diagnosis of suspected CAA. The pathophysiology of microbleeds and ICH in CAA is not well understood, but it is thought to be the result of vessel weakening and rupture secondary to amyloid deposition. Little evidence has been established pertaining to the time course of recurrent CAA-related microbleeds or larger hemorrhages. Although several risk factors have been associated with an increased risk of ICH in CAA, there are no current treatment guidelines for recurrent hemorrhaging in CAA.
CASE REPORT: We present a rare case of rapidly sequential and fatal lobar hemorrhaging in the setting of suspected CAA, diagnosed by numerous microbleeds on MRI, compounded by the use of subcutaneous heparin in a 63-year-old female patient.
CONCLUSIONS: This case broadens our understanding of a rarely identified progression of CAA and illustrates the need for further investigation of the use of subcutaneous heparin in the setting of probable CAA.
Keywords: Cerebral Amyloid Angiopathy, Heparin, Intracranial Hemorrhages
SARS-CoV-2/COVID-19
22 February 2023 : Case report
Am J Case Rep In Press; DOI: 10.12659/AJCR.938732
22 February 2023 : Case report
Am J Case Rep In Press; DOI: 10.12659/AJCR.938761
16 March 2023 : Case report
Am J Case Rep 2023; 24:e938359
01 March 2023 : Case report
Am J Case Rep 2023; 24:e937955
In Press
17 Mar 2023 : Case report
Am J Case Rep In Press; DOI: 10.12659/AJCR.939411
17 Mar 2023 : Case report
Am J Case Rep In Press; DOI: 10.12659/AJCR.939474
16 Mar 2023 : Case report
Am J Case Rep In Press; DOI: 10.12659/AJCR.938752
15 Mar 2023 : Case report
Am J Case Rep In Press; DOI: 10.12659/AJCR.938875
Most Viewed Current Articles
13 Jul 2022 : Case report
DOI :10.12659/AJCR.936441
Am J Case Rep 2022; 23:e936441
06 Dec 2021 : Case report
DOI :10.12659/AJCR.934406
Am J Case Rep 2021; 22:e934406
23 Feb 2022 : Case report
DOI :10.12659/AJCR.935250
Am J Case Rep 2022; 23:e935250
07 Dec 2021 : Case report
DOI :10.12659/AJCR.934347
Am J Case Rep 2021; 22:e934347